Skip to main content
. 2019 Jul 29;41(1):704–717. doi: 10.1080/0886022X.2019.1642210

Figure 3.

Figure 3.

Regression analysis of miR-193a, WT1, or PODXL levels for renal survival among IMN patients (A), IMN patients at stage I (B), IMN patients at stage II (C), and IMN patients at stages III + IV (D). PODXL: podocalyxin; IMN: idiopathic membranous nephropathy.